Thank you for registering for an interactive Meet The Expert Session(s) during the ESH 3rd How to Diagnose and Treat Acute Leukaemias E-Conference. Details will be sent to you by email.
Your seat (s) in the Meet the Expert session (s) will be definitively reserved upon receipt of your fee. To access the payment platform, CLICK HERE.
As seats are limited, if we do not receive your payment within the next 2 weeks, your registration in the Meet The Expert session (s) will be automatically canceled.
Meet the Expert Sessions are an opportunity for informal scientific exchange with a global authority in the field. These sessions are reserved for 25 to 30 participants only. They are open to academic biologists and clinicians only. They will take place 100% live and it will not be recorded. This means that you must be connected to the platform at the CET time indicated in the program. If you are not sure to join the meeting, please leave your seat open so that another participant can benefit.
Meet the Expert Sessions are interactive sessions. The Experts will be present to answer your questions and give you guidance. They will not give a formal presentation. Therefore, please be aware that by registering in this session, you agree to: turn on your webcam and microphone and ask at least one question during the session.
When you wish to ask a question or make a comment, please raise your hand and wait until the Experts give you the floor before turning your microphone on.
You will receive the link (s) to access the session (s) closer to the E-Conference.
How to Access?
The E-Conference Platform is now officially open.
To access the content reserved to registered participants (on demand programme – lectures and E-Posters, E-Book, live programme), you just need to enter the email address you used to register when required.
Now is a good time to check system requirements to avoid technical issues. Click here to run a test.
TIMING OF THE SCIENTIFIC PROGRAMME:
Participants will be joining us from all over the world and from different time zones. We want to make sure that everyone has access to the full scientific programme at a convenient hour. For this reason, registration allows you to join both the LIVE PROGRAMME and the recorded PROGRAMME ON-DEMAND.
The E-Conference platform will remain open from March 1 to April 13, 2022 so that you can view and revisit the programme’s full scientific content at times convenient to you.
THE LIVE PROGRAMME: March 10-13, 2022– CET time
Join us live for Interactive Cases with voting, Debates, Meet the Expert sessions, interactive panel discussions and Q&A, and Mentored Poster Walk. It will also include some pre-recorded lectures that will be streamed live, followed by their corresponding fully live Q&A period.
Consult the LIVE PROGRAMME here.
The PROGAMME ON-DEMAND: March 1 to April 13, 2022
Access the pre-recorded components of the scientific programme as of March 1, 2022. The meetings live components will be recorded real time and will progressively enrich the Programme on-demand (following speakers’ approval). Access to the meeting’s full scientific content will remain open on the E-Conference platform until April 13, 2022.
E-Posters: March 1 to April 13, 2022
The Poster Hall will also remain open until April 13, 2022.
The Mentored Poster Walk will be recorded real time. It will thereafter become available within the Programme on-demand.
SATELLITE SYMPOSIUM LIVE AND ON-DEMAND:
Symposia organized independently by our corporate partners in conjunction with the ESH 3rd How to Diagnose and Treat Acute Leukaemias E-Conference, will also be available Live and On-Demand, as described above.
VIRTUAL EXHIBITION: March 1 to April 13, 2022
We invite you to visit the E-Exhibition as of March 1, 2022. Our corporate partners will be pleased to welcome and chat with you.
If you have questions, please don’t hesitate to contact us at email@example.com.
We look forward to welcoming you to the ESH 3rd How to Diagnose and Treat Acute Leukaemias E-Conference.
In the meantime, stay safe!
The ESH team
ESH GENERAL TERMS AND CONDITIONS OF USE